ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Diet, Nutrition Committee To Rate Suggested Projects

January 9, 1976

Dial Access Offers Caner Consultation Services

February 21, 1975

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

NCI Offers Mouse Strains, Tissue Microarrays, Online.

March 9, 2001

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Chemotherapy Pioneer Howard Skipper Dead; His Work With Lekemia Cells In Mice Led To Development of Combination Therapies.

January 13, 2006